Donald W. Landry, M.D., Ph.D.
Donald W. Landry, M.D., Ph.D., is Professor of Medicine, Director
of the Division of Experimental Therapeutics, and Chair of the Department
of Medicine at Columbia University. Dr. Landry completed his Ph.D.
in Organic Chemistry under R.B. Woodward at Harvard University in
1979 and obtained the M.D. degree from Columbia University in 1983.
After completing Residency in Internal Medicine at the Massachusetts
General Hospital, he returned to Columbia to join the faculty of
Medicine. His basic research program focuses on drug discovery and
artificial enzyme approaches to intractable drug targets, e.g.,
cocaine addiction. His clinical research and clinical practice
centers on his discovery in critical care medicine that vasopressin
insufficiency contributes to vasodilatory shock and can be treated
by vasopressin infusion. He and Columbia colleague Howard Zucker
pioneered the alternative, embryo-sparing approach for the production
of human embryonic stem cells based on the harvesting of live cells
from dead embryos by extension of the established ethics for the
harvesting of essential organs from deceased donors.
:: Return to Council Member List ::